Skip to content

Polypeptide N-acetylgalactosaminyltransferase 14 (GALNT14)

Homo sapiens — UniProt Q96FL9

Gene: GALNT14Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Polypeptide N-acetylgalactosaminyltransferase 14 (GALNT14) is a protein from Homo sapiens identified by UniProt accession Q96FL9, 552 residues long. MolForge cross-references it against 0 known binders and 78 disease associations.

  • UniProt accession: Q96FL9; gene symbol GALNT14.
  • Organism: Homo sapiens.
  • Length: 552 amino acids.
  • Top disease associations (Open Targets): neurodegenerative disease, Non-immune hydrops fetalis and eosinophilic esophagitis.
  • 3D structure: AlphaFold model available.

Target properties

Protein namePolypeptide N-acetylgalactosaminyltransferase 14
UniProt accessionQ96FL9
GeneGALNT14
OrganismHomo sapiens
Length552 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (78)

Diseases linked to this target (Open Targets).

  • neurodegenerative disease · score 0.45
  • Non-immune hydrops fetalis · score 0.27
  • eosinophilic esophagitis · score 0.15
  • protein measurement · score 0.14
  • glioblastoma multiforme · score 0.14
  • volvulus of midgut · score 0.12
  • Intestinal malrotation · score 0.12
  • Familial intestinal malrotation - facial anomalies · score 0.12
  • hepatocellular carcinoma · score 0.09
  • breast cancer · score 0.08

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q96FL9-F1alphafoldPREDICTED89.04—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q96FL9.

Amino-acid sequence (552 residues)

MRRLTRRLVL PVFGVLWITV LLFFWVTKRK LEVPTGPEVQ TPKPSDADWD DLWDQFDERR YLNAKKWRVG DDPYKLYAFN QRESERISSN RAIPDTRHLR CTLLVYCTDL PPTSIIITFH NEARSTLLRT IRSVLNRTPT HLIREIILVD DFSNDPDDCK QLIKLPKVKC LRNNERQGLV RSRIRGADIA QGTTLTFLDS HCEVNRDWLQ PLLHRVKEDY TRVVCPVIDI INLDTFTYIE SASELRGGFD WSLHFQWEQL SPEQKARRLD PTEPIRTPII AGGLFVIDKA WFDYLGKYDM DMDIWGGENF EISFRVWMCG GSLEIVPCSR VGHVFRKKHP YVFPDGNANT YIKNTKRTAE VWMDEYKQYY YAARPFALER PFGNVESRLD LRKNLRCQSF KWYLENIYPE LSIPKESSIQ KGNIRQRQKC LESQRQNNQE TPNLKLSPCA KVKGEDAKSQ VWAFTYTQQI LQEELCLSVI TLFPGAPVVL VLCKNGDDRQ QWTKTGSHIE HIASHLCLDT DMFGDGTENG KEIVVNPCES SLMSQHWDMV SS

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with GALNT14?

The strongest Open Targets associations for GALNT14 are neurodegenerative disease, Non-immune hydrops fetalis, eosinophilic esophagitis, protein measurement and glioblastoma multiforme.

How long is the GALNT14 protein?

The Homo sapiens GALNT14 protein (UniProt Q96FL9) is 552 amino acids long.

Browse: Targets: G · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Polypeptide N-acetylgalactosaminyltransferase 14 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ96FL9
GeneGALNT14
OrganismHomo sapiens
Length552
Binders0
Diseases78
View on UniProt